Powder: -20°C for 3 years | In solvent: -80°C for 1 year
6-Thio-2'-Deoxyguanosine (β-TGdR) 是一种核苷类似物和端粒酶底物,可以通过端粒酶掺入重新合成的端粒中。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 193 | 现货 | ||
5 mg | ¥ 493 | 现货 | ||
10 mg | ¥ 690 | 现货 | ||
25 mg | ¥ 1,530 | 现货 | ||
50 mg | ¥ 2,530 | 现货 | ||
100 mg | ¥ 3,820 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 543 | 现货 |
产品描述 | 6-Thio-2'-Deoxyguanosine (β-TGdR) is a nucleoside analog and telomerase substrate. |
体外活性 | 6-Thio-dG induces telomere dysfunction and results in progressive telomere shortening in telomerase-positive human cancer cells and hTERT-expressing human fibroblasts. In tested cancer cells, 6-thio-dG inhibits cell viability with IC50 values between 0.7 and 2.9 μM. [1] |
体内活性 | In mice bearing A549 lung cancer xenografts, 6-Thio-dG (2 mg/kg, i.p.) decreases the tumorigenicity of A549 Cells by inducing telomere dysfunction. [1] |
细胞实验 | Cells are plated in growth media in 96-well plates. Cells are incubated for 1 week and treated with varying concentrations of 6-thio-dG and 6-thioguanine or DMSO every 3 days. The 96-well plates are analyzed according the manufacturer's directions for the CellTiterGlo luminescent cell viability assay to obtain IC50 values. The IC50 is defined as the concentration of drug at which 50% of the cells are inhibited by the drug. Sigmoidal dose–response curves are used to calculate IC50 values. All samples are analyzed in triplicate, and SDs are from two independent experiments.(Only for Reference) |
别名 | 6-Thio-dG, β-TGdR |
分子量 | 283.31 |
分子式 | C10H13N5O3S |
CAS No. | 789-61-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 52 mg/mL (183.5 mM)
H2O: < 1 mg/mL (insoluble or slightly soluble)
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 3.5297 mL | 17.6485 mL | 35.297 mL | 88.2426 mL |
5 mM | 0.7059 mL | 3.5297 mL | 7.0594 mL | 17.6485 mL | |
10 mM | 0.353 mL | 1.7649 mL | 3.5297 mL | 8.8243 mL | |
20 mM | 0.1765 mL | 0.8824 mL | 1.7649 mL | 4.4121 mL | |
50 mM | 0.0706 mL | 0.353 mL | 0.7059 mL | 1.7649 mL | |
100 mM | 0.0353 mL | 0.1765 mL | 0.353 mL | 0.8824 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
6-Thio-2'-Deoxyguanosine 789-61-7 Cell Cycle/Checkpoint DNA Damage/DNA Repair Others DNA/RNA Synthesis Inhibitor beta-TGdR 6-Thio-dG inhibit b-TGdR 6Thio2'Deoxyguanosine 6 Thio 2' Deoxyguanosine β-TGdR inhibitor